Skip to main content

Highlights

  1. 1
    Pediatric blood & cancer · 2022
    PMID: 36317671PMCID: PMC9878097DOIFirst author4 citations

Publications

30 publications

Funding

1 grant
Completed grants (1)
  • PI
    Use of single cell surface protein and gene expression studies to map immune alterations in female patients with chronic immune thrombocytopenia as compared to those with acute disease and systemic lupus erythematosus
    Foundation for Women & Girls with Blood Disorders · 2024–2025
    No publications yet
    FWGBD 240259-01

Clinical research

2 studies

Active

1 study
  • PI
    Blood biomarkers to predict course and response to therapy in Pediatric Immune Thrombocytopenia
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2024)
Completed & closed trials (1)
  • PI
    A Phase III Study of Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
    PHASE3 · Boston Children's Hospital (Children's Hospital Corporation) · CLOSED TO ACCRUAL (as of 2024)
    Immune Thrombocytopenia
    NCT03939637